rs864309503
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001303256.3(MORC2):c.754C>T(p.Arg252Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
MORC2
NM_001303256.3 missense
NM_001303256.3 missense
Scores
6
8
5
Clinical Significance
Conservation
PhyloP100: 3.14
Genes affected
MORC2 (HGNC:23573): (MORC family CW-type zinc finger 2) This gene encodes a member of the Microrchidia (MORC) protein superfamily. The encoded protein is known to regulate the condensation of heterochromatin in response to DNA damage and play a role in repressing transcription. The protein has been found to regulate the activity of ATP citrate lyase via specific interaction with this enzyme in the cytosol of lipogenic breast cancer cells. The protein also plays a role in lipogenesis and adipocyte differentiation. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), MORC2. . Gene score misZ 3.2251 (greater than the threshold 3.09). Trascript score misZ 4.4393 (greater than threshold 3.09). GenCC has associacion of gene with Leigh syndrome, Charcot-Marie-Tooth disease axonal type 2Z, developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.855
PP5
Variant 22-30941503-G-A is Pathogenic according to our data. Variant chr22-30941503-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 218307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-30941503-G-A is described in Lovd as [Likely_pathogenic]. Variant chr22-30941503-G-A is described in Lovd as [Pathogenic]. Variant chr22-30941503-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MORC2 | NM_001303256.3 | c.754C>T | p.Arg252Trp | missense_variant | 9/26 | ENST00000397641.8 | NP_001290185.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MORC2 | ENST00000397641.8 | c.754C>T | p.Arg252Trp | missense_variant | 9/26 | 5 | NM_001303256.3 | ENSP00000380763 | P1 | |
MORC2 | ENST00000215862.8 | c.568C>T | p.Arg190Trp | missense_variant | 10/27 | 1 | ENSP00000215862 | |||
MORC2 | ENST00000469915.1 | n.308C>T | non_coding_transcript_exon_variant | 3/6 | 3 | |||||
MORC2 | ENST00000675601.1 | n.596C>T | non_coding_transcript_exon_variant | 5/22 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:13Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2Z Pathogenic:9
Pathogenic, criteria provided, single submitter | research | Laboratório de Neurologia Aplicada e Experimental, Faculdade de Medicina de Ribeirao Preto – Universidade de Sao Paulo | Jul 20, 2021 | The p.Arg252Trp variant in the MORC2 gene has been reported in several families with Charcot-Marie-Tooth disease, type 2Z (AD-CMT2Z; OMIM: 616688). This variant is considered a hotspot, and most patients are sporadic cases (PMID: 30624633). This variant is also known as p.Arg190Trp in the literature. This variant is not present in population databases (GnomAD and ABraOM). ClinVar classifies this variant as Pathogenic (Variation ID: 218307), 2 stars (multiple consistent, 9 submissions), backed by functional studies (requires user validation) mentioned in 30624633, and also citing 10 articles (29440755, 28771897, 28581500, 27105987, 27105897 and 5 more). These amino acids are located in an important and highly conserved functional domain of the protein (GHKL-type ATPase). In summary, the p.Arg252Trp meets our criteria to be classified as pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 24, 2015 | - - |
Pathogenic, criteria provided, single submitter | research | Neurogenomics Lab, Neuroscience Institute, University Of Cape Town | May 22, 2024 | PM2_supporting: This variant is absent from gnomAD v4.0 (adequate coverage >20x confirmed) and an internal database of 1074 control alleles. PP2 met: missense Z-score is 3.23. PP1_strong: variant segregates with =5 informative meioses across =1 family. PP3 met: REVEL score is 0.70. PM1 met: variant occurs in the GHKL-type ATPase domain together with other pathogenic variants. PS3_supporting: functional studies provide supportive evidence that this variant has a damaging effect on the gene or gene product (PMID: 29440755, 28581500). PS4 met: variant identified in = 10 unrelated probands with consistent phenotype for disorder. Sequencing funded by the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD): https://www.ucl.ac.uk/genomic-medicine-neuromuscular-diseases/. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Jul 21, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Feb 23, 2023 | The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.70; 3Cnet: 0.67). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000218307). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 28771897). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Immunology and Genetics Kaiserslautern | Apr 25, 2024 | ACMG Criteria: PM2, PP3, PS3, PP5; Variant was found in heterozygous state - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 24, 2023 | This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease, type 2 (CMT2) (PMID: 26497905, 26659848, 26912637, 27105987). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 252 of the MORC2 protein (p.Arg252Trp). This variant is also known as p.Arg190Trp. ClinVar contains an entry for this variant (Variation ID: 218307). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MORC2 protein function. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 22, 2022 | Published functional studies demonstrate a damaging, gain-of-function effect (Tchasovnikarova et al., 2017; Douse et al., 2018); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26497905, 31372974, 27794525, 29440755, 28402445, 28334961, 7964809, 12601114, 27105987, 26659848, 27105897, 28251916, 28771897, 27329773, 30624633, 34059105, 33333791, 26912637, 28581500) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2017 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 10, 2017 | - - |
Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL) | Apr 27, 2023 | - - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria provided | research | Genesis Genome Database | Aug 14, 2019 | - - |
Distal spinal muscular atrophy Uncertain:1
Uncertain significance, no assertion criteria provided | research | Genesis Genome Database | Aug 14, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
D;.
Vest4
MutPred
Loss of sheet (P = 0.0037);.;
MVP
MPC
2.1
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at